Skip to main
Allstripes logo
IndividualsPatient organizationsPatient orgsLife sciencesAboutBlogResearch programsSign in
Search icon
Search
Research programs
Sign in

Why this tech company raised $50M to tackle dozens of rare diseases

August 24, 2021

Read on
San Francisco Business Times

More press releases

AllStripes announces $50 million Series B financing
August 24, 2021
AllStripes expands rare disease research programs to United Kingdom
February 12, 2021
AllStripes announces collaboration with Taysha Gene Therapies for SURF1-Associated Leigh syndrome program
January 4, 2021
AllStripes announces partnership with Penn’s Orphan Disease Center
October 26, 2020
View all
AllStripes logo
AllStripes Research
AllStripes is a Public Benefit Corporation on a mission to unlock new treatments for people affected by rare disease.
Learn more
ConditionsIndividualsPatient orgsLife sciencesInsights
Company
About
Careers
– We're hiring!
NewsBlog
Support
ContactFAQsTerms of usePrivacy policyAccessibility
© 2022 AllStripes | All rights reserved

Search for something

Popular links:
Programs
Individuals
About
Blog